AstraZeneca News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

12.12.20	AstraZeneca Agrees To Buy Alexion Pharma In $39 Bln Cash And Stock Deal (RTTNews)
11.12.20	Innate To Return US & EU Commercialization Rights Of Lumoxiti To AstraZeneca - Quick Facts (RTTNews)
10.12.20	AstraZeneca, Daiichi Sankyo: ENHERTU Demonstrated Durable Responses In Phase II Trial (RTTNews)
01.12.20	AstraZeneca To Sell Rights To Crestor In Over 30 European Countries To Grünenthal (RTTNews)
30.11.20	AstraZeneca Announces Approval Of Forxiga In Japan For Chronic Heart Failure (RTTNews)
30.11.20	Biotech Stocks Facing FDA Decision In December 2020 (RTTNews)
27.11.20	AstraZeneca Likely To Run New Global Trial Of COVID-19 Vaccine (RTTNews)
27.11.20	AstraZeneca, Oxford Acknowledge Manufacturing Error In Potential COVID-19 Vaccine (RTTNews)
26.11.20	The Long And Short Of Pfizer-BioNTech, Moderna, Sputnik V & Oxford-AstraZeneca Vaccines (RTTNews)
24.11.20	AZN's COVID Shot 70% Effective On Average, ARQT Aces Scalp Psoriasis Study, BLRX' BLAST Fizzles (RTTNews)
23.11.20	Astrazeneca Says Covid Vaccine 70% Effective; To Seek Early Approval (RTTNews)
20.11.20	AstraZeneca: FDA Approves New Dosing Option For Imfinzi - Quick Facts (RTTNews)
20.11.20	AZN's Covid Jab & Immunosenescence, PFE/BNTX To Seek Emergency Nod For Vaccine, QURE Aces HOPE-B (RTTNews)
19.11.20	Oxford-AstraZeneca Covid-19 Vaccine Shows Good Immune Response In Older People (RTTNews)
19.11.20	Oxford-AstraZeneca COVID-19 Vaccine Candidate Shows Strong Immune Response In Older Adults (RTTNews)
16.11.20	COVID-19 Vaccines - The Blues And Ease Of Cold Storage (RTTNews)
13.11.20	AZN's Repurposed COVID-19 Drug Fails, NAVB On Watch, CVAC Rallies On Storage Advantage Of CVnCoV (RTTNews)
10.11.20	Pre-market Movers In Healthcare Sector: ALT, AFMD, BNTX, PFE, AZN, SUPN… (RTTNews)
10.11.20	AstraZeneca, Amgen Report Positive Results From Tezepelumab Trial In Severe Asthma (RTTNews)
09.11.20	AstraZeneca: EU Approves Calquence To Treat Chronic Lymphocytic Leukaemia (RTTNews)
06.11.20	AstraZeneca: Brilinta Approved In US To Reduce Risk In Ischaemic Stroke (RTTNews)
05.11.20	AstraZeneca Q3 Profit Surges, Backs FY20 View; EU Approves Forxiga, Lynparza (RTTNews)
05.11.20	AstraZeneca: EU Approves Lynparza For Prostate Cancer, Ovarian Cancer (RTTNews)
05.11.20	AstraZeneca: Forxiga Gets EU Approval For Heart Failure - Quick Facts (RTTNews)
05.11.20	AstraZeneca Q3 Profit More Than Doubles; Confirms FY20 Forecast - Quick Facts (RTTNews)
04.11.20	Pre-market Movers In Healthcare Sector: DRAD, SUPN, ARGX, AZN, APVO… (RTTNews)
02.11.20	Fusion Pharma, AstraZeneca Collaborate To Develop Next-Gen Therapies - Quick Facts (RTTNews)
30.10.20	AstraZeneca To Divest Atacand In 70 Countries To Cheplapharm In $400 Mln Deal (RTTNews)
29.10.20	AstraZeneca: FASENRA Eliminates Oral Corticosteroid Use In Asthma Patients (RTTNews)
28.10.20	AstraZeneca: Forxiga Cardiovascular Outcomes Benefit Approved In China (RTTNews)
28.10.20	AstraZeneca : Enhertu Granted Priority Review In US For Metastatic Gastric Cancer Treatment (RTTNews)
26.10.20	Fauci Says Covid Vaccine's Safety, Efficacy Will Be Known By Dec (RTTNews)
22.10.20	AstraZeneca Covid-19 Vaccine Trial In Brazil To Continue Despite Volunteer's Death (RTTNews)
20.10.20	AstraZeneca: FDA Accepts Tagrisso SNDA, Granted Priority Review For Adjuvant Treatment (RTTNews)
19.10.20	AstraZeneca's Trixeo Aerosphere Gets Positive CHMP Opinion For COPD Treatment (RTTNews)
19.10.20	AstraZeneca: CHMP Recommends Forxiga For Approval In EU For Heart Failure - Quick Facts (RTTNews)
14.10.20	LLY Pauses COVID-19 Antibody Trial, JNJ Boosts Annual Outlook, Double Whammy For GOSS (RTTNews)
13.10.20	J&J Pauses Late-stage COVID-19 Vaccine Trial On Unexplained Illness (RTTNews)
12.10.20	AstraZeneca's COVID-19 AZD7442 Antibodies Advance Into 2 Phase III Trials; Gets $486 Mln U.S. Fund (RTTNews)
06.10.20	GSK, AZN 1st To Use NVDA's Supercomputer, IOVA To Delay BLA Filing, YMAB Plunges, GLYC On Watch (RTTNews)
02.10.20	EU Begins 1st Rolling Review Of COVID-19 Vaccine, SLDB To Restart DMD Trial, ENLV Soars, TARA Abuzz (RTTNews)
02.10.20	AstraZeneca's Farxiga Granted Breakthrough Therapy Designation In U.S. For Chronic Kidney Disease (RTTNews)
23.09.20	US Health Secretary Says AstraZeneca's Coronavirus Vaccine Trial Remains On Hold In US: CNBC (RTTNews)
21.09.20	AstraZeneca: Lynparza Recommended For Approval In EU For Prostate Cancer, Ovarian Cancer (RTTNews)
18.09.20	AstraZeneca: LYNPARZA Shows Progression-free Survival Benefit In Five-year Follow-up Data (RTTNews)
14.09.20	AstraZeneca Covid Vaccine Trial Resumption In US Not Yet Known; UK Trial Resumed (RTTNews)
10.09.20	AstraZeneca: Fasenra PhIII OSTRO Trial Meets Co-primary Endpoints; To List ADRs On Nasdaq (RTTNews)
09.09.20	AZN Pauses COVID-19 Vaccine Trial, ALBO Hits New High, CRBP Plunges, PFE To Invest In TRIL (RTTNews)
09.09.20	AstraZeneca halts Late-stage COVID-19 Vaccine Trial After U.K. Participant Falls Ill (RTTNews)
01.09.20	Astrazeneca Covid-19 Vaccine Candidate Enters Late-stage Study In US (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	74.30	1.53 %	K V
Holcim	87.38	1.49 %	K V
Roche Hldg G	251.00	1.46 %	K V
Swiss Re	130.35	1.44 %	K V
UBS Group	27.07	1.35 %	K V
Swisscom	501.00	0.52 %	K V
Lonza Grp	532.40	0.26 %	K V
Nestle	74.08	0.14 %	K V
Sonova Hldg	295.60	0.00 %	K V
Geberit	512.20	-0.39 %	K V

mehr

13:27		AstraZeneca-Aktie dennoch fester: AstraZeneca und Daiichi Sankyo rudern bei EU-Zulassungsantrag für Lungenkrebsmittel zurück
23.12.24		AstraZeneca-Aktie höher: EU-Zulassung für Tagrisso gegen weitere Lungenkrebsform
18.12.24		Schwacher Handel in New York: NASDAQ 100 am Mittwochnachmittag schwächer
04.12.24		Zuversicht in New York: NASDAQ 100 zum Handelsstart freundlich
03.12.24		Starker Wochentag in New York: NASDAQ 100 steigt zum Handelsende
03.12.24		Starker Wochentag in New York: NASDAQ 100 am Nachmittag mit Kursplus
03.12.24		Schwacher Wochentag in New York: NASDAQ 100 fällt am Mittag zurück
03.12.24		NASDAQ-Handel NASDAQ 100 zum Handelsstart schwächer

13:27

AstraZeneca-Aktie dennoch fester: AstraZeneca und Daiichi Sankyo rudern bei EU-Zulassungsantrag für Lungenkrebsmittel zurück

23.12.24

AstraZeneca-Aktie höher: EU-Zulassung für Tagrisso gegen weitere Lungenkrebsform

18.12.24

Schwacher Handel in New York: NASDAQ 100 am Mittwochnachmittag schwächer

04.12.24

Zuversicht in New York: NASDAQ 100 zum Handelsstart freundlich

03.12.24

Starker Wochentag in New York: NASDAQ 100 steigt zum Handelsende

03.12.24

Starker Wochentag in New York: NASDAQ 100 am Nachmittag mit Kursplus